Science

Ufovax Announces Its Self-Assembling NanoParticles as the Next-Generation Vaccine Solution for COVID-19

Friday, September 18, 2020 - 12:32am

Ufovax holds an exclusive global license to the Scripps Intellectual Property covering the platform and several vaccines, including COVID-19.

Key Points: 
  • Ufovax holds an exclusive global license to the Scripps Intellectual Property covering the platform and several vaccines, including COVID-19.
  • In a publication submitted Monday, September 14 (now available on the bioRxiv preprint server ), the authors present a systematic study on rational vaccine design and evaluation of vaccine response in mice.
  • In particular, Zhu and his team propose a new spike antigen design (S2GHR2) and displayed it on several SApNPs as COVID-19 vaccine candidates.
  • In practice, we have seen similar performance from the Merck HPV Gardasil vaccine which is essentially a protein nanoparticle vaccine.

GORE PHASEFLEX Microwave/RF Test Assemblies Honored, Set Gold Standard With Industry Innovators Award

Friday, September 18, 2020 - 12:00am

W. L. Gore & Associates announced today that its GORE PHASEFLEX Microwave/RF Test Assemblies were recognized among the 2020 Military & Aerospace Electronics Innovators Awards.

Key Points: 
  • W. L. Gore & Associates announced today that its GORE PHASEFLEX Microwave/RF Test Assemblies were recognized among the 2020 Military & Aerospace Electronics Innovators Awards.
  • The reliability of the test system is crucial, and the microwave/RF test cable assemblies are a critical piece.
  • GORE PHASEFLEX Microwave/RF Test Assemblies are the lifeline between the test equipment and the mission-critical systems under test.
  • GORE PHASEFLEX Microwave/RF Test Assemblies meet rigorous environmental challenges including temperature changes, moisture, shock, vibration, mechanical stress and flexure.

BeiGene Presents Data at ESMO Virtual Congress 2020 on Phase 3 Trial of Tislelizumab in First-Line Non-Squamous Non-Small Cell Lung Cancer and Phase 2 Trial of Pamiparib in Advanced Ovarian Cancer

Thursday, September 17, 2020 - 11:05pm

Our hope is to advance our broad tislelizumab development program in lung cancer to potentially improve treatment outcomes for the most prevalent cancer, both globally and in China.

Key Points: 
  • Our hope is to advance our broad tislelizumab development program in lung cancer to potentially improve treatment outcomes for the most prevalent cancer, both globally and in China.
  • Pamiparib demonstrated strong antitumor activity in patients with advanced ovarian cancer, having achieved clinically meaningful and durable responses in both platinum-sensitive and platinum-resistant patients with BRCA1/2 mutation.
  • The preliminary results presented at ESMO 2020 were from a Phase 2 dose-expansion portion of a Phase 1/2 trial of pamiparib in patients with advanced ovarian cancer, fallopian cancer, and primary peritoneal cancer or advanced triple negative breast cancer (NCT03333915).
  • To learn more about the data presented at the ESMO Virtual Congress 2020 and BeiGenes clinical pipeline, visit our virtual booth at https://beigenemedical.eu/ .

AFWERX Announces GigaIO Among Top Teams Selected to Exhibit at EngageSpace (September 29-30), The Premier Event for the Space Industry

Thursday, September 17, 2020 - 9:30pm

AFWERX, the catalyst for fostering innovation within the U.S. Air Force, announced GigaIO as one of the 178 top participating teams selected from The AFWERX Space Challenge initiative to exhibit at EngageSpace , a virtual two-day event on September 29-30.

Key Points: 
  • AFWERX, the catalyst for fostering innovation within the U.S. Air Force, announced GigaIO as one of the 178 top participating teams selected from The AFWERX Space Challenge initiative to exhibit at EngageSpace , a virtual two-day event on September 29-30.
  • Four challenges were run concurrently focused on separate topics Persistent ISR, DoD Commercial Space Partnerships, Global Space Transport and Delivery and Space Asset Resiliency.
  • The solutions submitted for these space challenges represent the bleeding edge of space innovation, stated Brennan Townley, AFWERX Challenge Collaboration Lead.
  • Were honored to be among the top innovative teams selected to participate in AFWERX virtual Space Event, said Alan Benjamin, CEO of GigaIO.

SAIC Announces Retirement of Jim Scanlon and Company Reorganization

Thursday, September 17, 2020 - 9:15pm

For more than three decades, Jim has been an important leader in shaping the SAIC we all know today.

Key Points: 
  • For more than three decades, Jim has been an important leader in shaping the SAIC we all know today.
  • This structure will enable SAIC to accelerate strategic growth priorities in areas such as digital engineering, digital transformation, and space.
  • With a distinguished career at SAIC spanning over 30 years, Scanlon has played pivotal roles and made remarkable contributions to the company.
  • Scanlon will remain with the company until January 29 to support a smooth transition to the new organization structure.

QIAGEN fully acquires NeuMoDx Molecular, Inc., rounding out portfolio of PCR-based diagnostic automation systems

Thursday, September 17, 2020 - 9:05pm

The move rounds out QIAGENs portfolio of automated molecular testing solutions based on the proven PCR technology.

Key Points: 
  • The move rounds out QIAGENs portfolio of automated molecular testing solutions based on the proven PCR technology.
  • The transaction was completed after QIAGEN received U.S. regulatory clearance for the full acquisition.
  • In 2018, QIAGEN had purchased a 19.9% stake in NeuMoDx along with the right to acquire the remaining NeuMoDx stake at a price of $234 million.
  • The full integration of the NeuMoDx systems will allow QIAGEN to address laboratory needs in almost any setting for molecular diagnostics.

2021 Syngenta Crop Challenge in Analytics highlights increasing importance of data analytics for agriculture industry

Thursday, September 17, 2020 - 6:25pm

Syngenta Seeds and the Analytics Society of INFORMS today launched the 2021 Syngenta Crop Challenge in Analytics, a competition that focuses on analytical approaches to improve complex crop breeding processes.

Key Points: 
  • Syngenta Seeds and the Analytics Society of INFORMS today launched the 2021 Syngenta Crop Challenge in Analytics, a competition that focuses on analytical approaches to improve complex crop breeding processes.
  • Now in its sixth consecutive year, the Syngenta Crop Challenge in Analytics is a collaborative effort between Syngenta Seeds and the Analytics Society of the Institute for Operations Research and the Management Sciences ( INFORMS ).
  • Established in 2015, the Syngenta Crop Challenge in Analytics is supported by Syngenta Seeds and hosted by the Analytics Society of INFORMS.
  • For more information about the Syngenta Crop Challenge in Analytics, including eligibility criteria and deliverables, visit www.ideaconnection.com/syngenta-crop-challenge .

North County Biotech Laboratories Has Immediate Availability of Single-Tenant, Fully Equipped Laboratory Spaces for Life Science Companies in the San Diego Region

Thursday, September 17, 2020 - 5:47pm

North County Biotech Laboratories (NCBL), provider of fully equipped, private, and secure laboratories with offices in North County San Diego for development and growth of innovative, novel therapies and medicines, announces immediate availability.

Key Points: 
  • North County Biotech Laboratories (NCBL), provider of fully equipped, private, and secure laboratories with offices in North County San Diego for development and growth of innovative, novel therapies and medicines, announces immediate availability.
  • Our private, lockable labs provide the independence, privacy and confidentiality that corporate research demands, says Dexter Gaston, Managing Partner of North County Biotech Laboratories.
  • What a service North County Biotech Laboratories provides to the life science community in Southern California.
  • North County Biotech Laboratories (NCBL) founded its private, fully equipped labs to advance research in innovative, novel therapies and medicines.

DeciBio Analytics launches Dexter, an expert network marketplace for the life science industry

Thursday, September 17, 2020 - 5:36pm

DeciBio Analytics, the market intelligence subsidiary of DeciBio Consulting, a precision medicine strategy consulting firm, has launched an expert network marketplace named Dexter.

Key Points: 
  • DeciBio Analytics, the market intelligence subsidiary of DeciBio Consulting, a precision medicine strategy consulting firm, has launched an expert network marketplace named Dexter.
  • Dexter customers receive market intelligence by leveraging Dexters life science expert network for 1:1 interviews and pulse surveys.
  • The Dexter network spans various life science cohorts including - but not limited to - single cell genomics, liquid biopsy, pathology, proteomics, and oncology.
  • DeciBio Consultings market intelligence subsidiary, DeciBio Analytics aggregates public and proprietary data to build proprietary data visualization and software products.

PPD Named a Top 50 Employer in Bulgaria

Thursday, September 17, 2020 - 5:00pm

PPD, Inc. (Nasdaq: PPD ), has been recognized as a top employer in Bulgaria, adding to the global contract research organizations growing list of accolades as an employer of choice around the world.

Key Points: 
  • PPD, Inc. (Nasdaq: PPD ), has been recognized as a top employer in Bulgaria, adding to the global contract research organizations growing list of accolades as an employer of choice around the world.
  • PPD was recognized as a top 50 desirable employer in Bulgaria, according to the second annual Employer of Choice Survey organized by the employer brand and business consulting agency To The Top.
  • Bulgaria has a large pool of highly trained health care professionals with extensive language capabilities, and PPD has multiple internships opportunities with medical and pharmacy schools in the area.
  • We are proud of the strong reputation our company has established as a leading employer in Bulgaria.